SI
Sofinnova Investments Portfolio holdings
AUM
$1.47B
This Quarter Return
+9.08%
1 Year Return
+17.43%
3 Year Return
+337.79%
5 Year Return
+424.38%
10 Year Return
–
AUM
$1.47B
AUM Growth
+$1.47B
(-10%)
Cap. Flow
-$134M
Cap. Flow
% of AUM
-9.12%
Top 10 Holdings %
Top 10 Hldgs %
65.38%
Holding
60
New
12
Increased
13
Reduced
12
Closed
9
Top Buys
| 1 |
Eli Lilly
LLY
|
$47.1M |
| 2 |
Intuitive Surgical
ISRG
|
$38.2M |
| 3 |
Biogen
BIIB
|
$36.9M |
| 4 |
Merck
MRK
|
$25.3M |
| 5 |
PTC Therapeutics
PTCT
|
$25M |
Top Sells
| 1 |
Sanofi
SNY
|
$95.2M |
| 2 |
CINC
CinCor Pharma, Inc. Common Stock
CINC
|
$74.6M |
| 3 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
$54.5M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
$45.3M |
| 5 |
AstraZeneca
AZN
|
$41.6M |
Sector Composition
| 1 | Healthcare | 99.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Vir Biotechnology
VIR
$765M
| $15.3M | 0.98% |
+657,559
| New | +$15.3M |
|
27
Celldex Therapeutics
CLDX
$1.57B
| $15.1M | 0.97% |
+419,397
| New | +$15.1M |
|
|
RXDX
28
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
| $13.3M | 0.85% |
123,842
-52,703
| -30% | -$5.66M |
|
29
Cytokinetics
CYTK
$5.98B
| $12.5M | 0.8% |
353,796
-155,134
| -30% | -$5.46M |
|
|
CTIC
30
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $11.7M | 0.75% |
2,794,542
-1,811,985
| -39% | -$7.61M |
|
31
Y-mAbs Therapeutics
YMAB
$390M
| $11M | 0.7% |
2,194,278
| – | – |
|
|
AGEN
32
Agenus
AGEN
$136M
| $9.74M | 0.62% |
6,407,457
+3,513,400
| +121% | +$5.34M |
|
|
MRNS
33
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $8.28M | 0.53% |
+1,200,389
| New | +$8.28M |
|
|
GRTX
34
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
| $7.89M | 0.5% |
3,083,712
| – | – |
|
35
Kura Oncology
KURA
$732M
| $7.54M | 0.48% |
616,169
+22,608
| +4% | +$276K |
|
36
Axsome Therapeutics
AXSM
$6.09B
| $7.46M | 0.48% |
+120,896
| New | +$7.46M |
|
37
IDEAYA Biosciences
IDYA
$2.26B
| $6.22M | 0.4% |
453,149
-21,381
| -5% | -$294K |
|
|
NCNA
38
NuCana
NCNA
$5.8M
| $5.38M | 0.34% |
5,599,999
| – | – |
|
39
Revolution Medicines
RVMD
$7.43B
| $3.98M | 0.25% |
+183,838
| New | +$3.98M |
|
40
NextCure
NXTC
$13.3M
| $3.95M | 0.25% |
2,671,856
| – | – |
|
41
Bolt Biotherapeutics
BOLT
$9.29M
| $3.83M | 0.24% |
2,754,437
| – | – |
|
|
IMGN
42
DELISTED
Immunogen Inc
IMGN
| $3.55M | 0.23% |
924,532
-761,622
| -45% | -$2.92M |
|
43
Keros Therapeutics
KROS
$640M
| $3.29M | 0.21% |
+77,100
| New | +$3.29M |
|
|
BLUE
44
DELISTED
bluebird bio
BLUE
| $2.14M | 0.14% |
+672,815
| New | +$2.14M |
|
45
PDS Biotechnology
PDSB
$60.6M
| $877K | 0.06% |
142,635
| – | – |
|
|
FUSN
46
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
| $441K | 0.03% |
117,099
| – | – |
|
47
Synlogic
SYBX
$17.4M
| $363K | 0.02% |
574,972
| – | – |
|
48
Alnylam Pharmaceuticals
ALNY
$58.6B
| $89.7K | 0.01% |
448
-56,000
| -99% | -$11.2M |
|
49
Align Technology
ALGN
$9.59B
| – | – |
-83,100
| Closed | -$17.5M |
|
|
50
AstraZeneca
AZN
$255B
| – | – |
-613,673
| Closed | -$41.6M |
|